Bifogade filer
Observe_Medical_ASA_debt_restructuring_April_10_2025
Beskrivning
| Land | Norge |
|---|---|
| Lista | OAX Equities |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
2025-04-10 08:50:09
Oslo, April 10[th], 2025 - Observe Medical ("the Company" or "Observe Medical")
have reached agreements in principle with Convatec and Navamedic to reduce their
debt position from in total NOK 82 million to NOK 41 million, with an adjusted
payment plan for the remaining debt. Such debt reduction is conditional upon
injection of new equity in the minimum amount of NOK 25 million.
The Company has also been in constructive dialogue with existing shareholders
and new investors who have indicated willingness to contribute equity in an
amount of NOK 25 million, subject to debt reductions being agreed. The
agreements in principle with Convatec and Navamedic will partially cover the
requirement from such investors. Similar negotiations with smaller unsecured
creditors will also be initiated.
It is currently considered likely that an equity raise (if initiated) will take
the form of a private placement and a subsequent repair offering, but the final
transaction structure remains to be determined. Furthermore, final commitments
from the investors who have expressed willingness to participate have not yet
been retained and no assurance can at this stage be given that the contemplated
refinancing will be completed.
For further information, please contact:
Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com
Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com
This information is considered to be inside information pursuant to the EU
Market Abuse Regulation and is subject to the disclosure requirements pursuant
to section 5-12 the Norwegian Securities Trading Act.
This stock exchange announcement was published by Johan Fagerli, CFO of the
Company, on 10 April 2025 at 08:50 hours CET on behalf of the Company.
About Observe Medical
Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.
The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.
The Company is headquartered in Oslo, Norway.
Further information is available at www.observemedical.com.